Phenotypic Drug Screening for Dysferlinopathy Using Patient‐Derived Induced Pluripotent Stem Cells
Abstract Dysferlinopathy is a progressive muscle disorder that includes limb‐girdle muscular dystrophy type 2B and Miyoshi myopathy (MM). It is caused by mutations in the dysferlin (DYSF) gene, whose function is to reseal the muscular membrane. Treatment with proteasome inhibitor MG‐132 has been sho...
Guardado en:
Autores principales: | Yuko Kokubu, Tomoko Nagino, Katsunori Sasa, Tatsuo Oikawa, Katsuya Miyake, Akiko Kume, Mikiko Fukuda, Hiromitsu Fuse, Ryuichi Tozawa, Hidetoshi Sakurai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b07e2c3175334def8fbba6cc177a30d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Low Intensity Training Provokes Adaptations on Muscle Fibrosis of a Muscular Dystrophy Model
por: Pinto,Priscilla Avelino Ferreira, et al.
Publicado: (2018) -
Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
por: He,Ruojie, et al.
Publicado: (2020) -
Distrofia muscular facioescapulohumeral en Chile: presentación de serie en hospital de referencia terciario
por: Cea,Gabriel, et al.
Publicado: (2015) -
FIBER MUSCLE TYPES IN ADULT FEMALE PIGS AS DETERMINED BY COMBINATING HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS
por: Graziotti,Guillermo H., et al.
Publicado: (2001) -
Molecular Diagnosis of Muscular Dystrophy Patients in Western Indian Population: A Comprehensive Mutation Analysis Using Amplicon Sequencing
por: Komal M. Patel, et al.
Publicado: (2021)